Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Drugs of Today (Barcelona, Spain : 1998)|December 4, 2009
PEGylation for improving the effectiveness of therapeutic biomoleculesGianfranco Pasut, Francesco M VeroneseDrug Discovery Today. Technologies|July 2, 2014
PEGylation: Posttranslational bioengineering of protein biotherapeuticsFrancesco M Veronese, Gianfranco PasutAdvanced Drug Delivery Reviews|August 13, 2009
PEG conjugates in clinical development or use as anticancer agents: an overviewGianfranco Pasut, Francesco M VeroneseJournal of Controlled Release : Official Journal of the Controlled Release Society|November 19, 2011
State of the art in PEGylation: the great versatility achieved after forty years of researchGianfranco Pasut, Francesco M VeroneseDrug Discovery Today|October 26, 2005
PEGylation, successful approach to drug deliveryFrancesco M Veronese, Gianfranco PasutAdvanced Drug Delivery Reviews|September 18, 2007
Anti-cancer PEG-enzymes: 30 years old, but still a current approachGianfranco Pasut, Mauro Sergi, Francesco M VeroneseMethods in Molecular Biology (Clifton, N.J.)|June 16, 2011
Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methodsAnna Mero, Chiara Clementi, Francesco M Veronese, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2011
A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormoneAnna Mero, Mariano Schiavon, Francesco M Veronese, et al.Pharmaceutical Research|May 26, 2011
Multivalent and flexible PEG-nitrilotriacetic acid derivatives for non-covalent protein pegylationAnna Mero, Tetsuya Ishino, Irwin Chaiken, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 13, 2012
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factorAnna Mero, Zhihao Fang, Gianfranco Pasut, et al.Pageof 11